TEDDY Network, through its European dimension, is arisen with the aim to promote the development of children tailored medicines, covering thus the existing gap at European and global level, deriving from the insufficient diffusion at the clinical centers of adequate experience and formation to perform paediatric research activities efficiently. TEDDY intends to achieve this goal, through the achievement of the following objectives:
- Promote and provide methodological expertise to set up, develop and conduct paediatric national or multinational clinical trials and other paediatric studies.
- To collaborate with existing paediatric networks and research organisations in the framework of the Enpr-EMA (the European Network of paediatric research at the EMA) and other international initiatives, such as GRiP, the FP7 Project that is aimed at implementing an infrastructure to stimulate and facilitate the development and the safe use of medicines in children.
- To develop informative tools (tailored to industries, public agencies, researchers, health professionals, ethics committees and patients/parents organisations) in order to increase awareness on the topics of paediatric research.
- To develop communication and educational tools tailored for children in order to facilitate their participation in all the relevant experimental procedures including assent and consent forms preparation.
- Develop education and training programmes addressed to professionals, researchers, technicians and healthcare professionals to favor the knowledge in the paediatric research field;
- Favor the access of the paediatric ages to the main finding of the research in life sciences, including the knowledge translation from biology, biotechnology, genomics and innovative methodologies in the clinical studies.
TEDDY activities are addressed to national, European and international Authorities, public and private Institutions and Companies devoted to Research and Care, Pharmaceuticals Companies, researchers, professionals and Patients’ Associations.